Molecular epidemiological characteristics of clinically isolated carbapenem-resistant Acinetobacter baumannii in Changsha

Journal of Central South University (Medical Sciences)

Volumn 37, Issue 5, 2012, Pages 521-526

  Liang, Wei ^a,b   Zou, Mingxiang ^a   Wu, Jingmin ^a   Wu, Guojun ^c   Li, Jun ^a   Dou, Qjngya ^a   Liu, Wenen ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Third Hospital of Changsha   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Acinetobacter baumannii; Carbapenemases; Enterbacter repetitive intergenic consensus pcr; Molecular epidemiological characteristics

Indexed keywords

BACTERIAL DNA; CARBAPENEM DERIVATIVE; PIPERACILLIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; CHINA; DRUG EFFECT; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; REVIEW;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; CARBAPENEMS; CHINA; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MOLECULAR EPIDEMIOLOGY; PIPERACILLIN; POLYMERASE CHAIN REACTION;

EID: 84862752026     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2012.05.018     Document Type: Review

References (13)

1. ZHU Demei, WANG Fu, HU Fupin, et al. CHINET 2010 surveillance ofbacterial resistance in China[J]. Chinese Journal of Infection and Chemotherapy, 2011, 11(5):321-329.
2. Perez F, Hujer AM, Hujer KM, et al. Global challenge of multidrugresistant Acinetobacter baumannii[J]. Antimicrob Agents Chemother, 2007, S1(10):3471-3484. (Pubitemid 47519332)
3. CHEN Baiyi, HE Lixian, HU Bijie, et al. Diagnosis, treatment, prevention and control of Acinetobacter baumannii infection in China[J]. National Medical Journal of China, 2012, 92(2):76-85.
4. Amudhan SM, Sekar U, Arunagiri K, et al. OXA beta-lactamasemediated carbapenem resistance in Acinetobacter baumannii[J]. Indian J Med Microbiol, 2011, 29(3):269-274.
5. Jeong SH, Bae IK, Park KO, et al. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea[J]. J Clin Microbiol, 2006, 44(4):423-431.
6. ZHOU Xiuzhen, LIU Jianhua, WHANG Yanling, et al. Dynamicchanges of drug resistance and infectious distribution of Acinetobacter baumannii for twelve successive years[J]. The Chinese Journal of Clinical Pharmacology, 2011, 27(10):758-758.
7. FAN Yanping, ZHANG Yihua, LI Xiuwen, et al. Clinical distribution and drug-resistance of Acinetobacter baumannii isolated from 2006 to 2009[J]. Chinese Journal of Antibiotics, 2010, 36(6):483-485.
8. LI Yun, LU Yuan, WANG Shan. Mohnarin report 2010:surveillance of antimicrobial resistance in nonfermenting gram-negative bacteria[J]. Chinese Journal of Nosocomiology, 2011, 21(24) :5133-5137.
9. LIU Yuan, TAN Xiangshu, HAN Xingpeng. Carbapenemases and homology of imipenem resistant Acinetobacter baumannii isolates in Xi'an[J]. Chinese Journal of Infection and Chemotherapy, 2009, 9(1):37-41.
10. ZHANG Weihong, YE Huifen, YANG Yinmei, et al. Antibiotic resistant phenotype and carbapenemase genotype analysis of imipenem resistant Acinetobacter baumannii[J]. Chinese Journal of infection and Chemotherapy,2011, 11(1):45-48.
11. Hammami S, Ghozzi R, Saidani M, et al. Carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in Tunisia[J]. Tunis Med, 2011, 89(7):638-643.
12. WANG Li, WANG Feng, WANG Weihua, et al. Study of molecular epidemiology and resistance mechanism of multiple drug resistant Acinetobacter baumannii[J]. Chinese Journal of Microbiology and Immunology, 2011, 31(4):343-344.
13. Hu Q, Hu Z, Li J, et al. Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China[J]. J Basic Microbiol, 2011, 51(5):467-472.